Suivre
Niladri Ganguly
Niladri Ganguly
Adresse e-mail validée de kiitbiotech.ac.in
Titre
Citée par
Citée par
Année
Human papillomavirus E6 and E7 oncoproteins as risk factors for tumorigenesis
N Ganguly, SP Parihar
Journal of biosciences 34 (1), 113-123, 2009
2352009
CAR T cell therapy: A new era for cancer treatment
R Mohanty, CR Chowdhury, S Arega, P Sen, P Ganguly, N Ganguly
Oncology reports 42 (6), 2183-2195, 2019
2042019
Role of M. tuberculosis RD-1 region encoded secretory proteins in protective response and virulence
N Ganguly, I Siddiqui, P Sharma
Tuberculosis 88 (6), 510-517, 2008
1392008
Mycobacterium tuberculosis secretory proteins CFP‐10, ESAT‐6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide‐induced NF‐κB transactivation by …
N Ganguly, PH Giang, C Gupta, SK Basu, I Siddiqui, DM Salunke, ...
Immunology and cell biology 86 (1), 98-106, 2008
1382008
Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer
P Sen, P Ganguly, N Ganguly
Oncology letters 15 (1), 11-22, 2018
882018
Mycobacterium tuberculosis 6-kDa Early Secreted Antigenic Target (ESAT-6) protein downregulates Lipopolysaccharide induced c-myc expression by modulating …
N Ganguly, PH Giang, SK Basu, FA Mir, I Siddiqui, P Sharma
BMC immunology 8, 1-12, 2007
662007
Human papillomavirus-16 E5 protein: oncogenic role and therapeutic value
N Ganguly
Cellular oncology 35, 67-76, 2012
472012
Mycobacterium tuberculosis secreted antigen (MTSA‐10) modulates macrophage function by redox regulation of phosphatases
SK Basu, D Kumar, DK Singh, N Ganguly, Z Siddiqui, KVS Rao, P Sharma
The FEBS journal 273 (24), 5517-5534, 2006
282006
Transcriptomic analyses of genes differentially expressed by high-risk and low-risk human papilloma virus E6 oncoproteins
P Ganguly, N Ganguly
Virusdisease 26, 105-116, 2015
182015
Role of long non‑coding RNAs and related epigenetic mechanisms in liver fibrosis
N Ganguly, S Chakrabarti
International Journal of Molecular Medicine 47 (3), 1-1, 2021
152021
Transcriptomic analyses of gene expression by CRISPR knockout of miR-214 in cervical cancer cells
P Sen, S Ghosal, R Hazra, S Arega, R Mohanty, KK Kulkarni, R Budhwar, ...
Genomics 112 (2), 1490-1499, 2020
142020
CRISPR-mediated knockdown of miR-214 modulates cell fate in response to anti-cancer drugs in HPV-negative and HPV-positive cervical cancer cells
P Sen, S Ghosal, R Hazra, R Mohanty, S Arega, B Sahu, N Ganguly
Journal of biosciences 45, 1-17, 2020
82020
Mycobacterium tuberculosis RD-1 secreted antigens as protective and risk factors for tuberculosis
N Ganguly, P Sharma
INTECH Open Access Publisher, 2012
82012
Mycobacterium tuberculosis secreted antigen (MTSA-10) inhibits macrophage response to lipopolysaccharide by redox regulation of phosphatases
SK Basu, D Kumar, N Ganguly, KVS Rao, P Sharma
CSIR, 2009
82009
Antibacterial and cytotoxic activity of polymer-metal hybrid nanoparticle
M Manoswini, D Bhattacharya, P Sen, N Ganguly, PS Mohanty
Advances in Natural Sciences: Nanoscience and Nanotechnology 12 (2), 025003, 2021
52021
In silico analysis of a novel protein in CAR T-cell therapy for the treatment of hematologic cancer through molecular modelling, docking, and dynamics approach
R Mohanty, M Manoswini, AK Dhal, N Ganguly
Computers in Biology and Medicine 151, 106285, 2022
32022
Differential transcriptome analysis in HPV-positive and HPV-negative cervical cancer cells through CRISPR knockout of miR-214
P Sen, P Ganguly, KK Kulkarni, R Budhwar, N Ganguly
Journal of biosciences 45 (1), 104, 2020
32020
Micro Rnas in Human Papillomavirus Mediated Cervical Cancer
N Ganguly
Austin Virol and Retrovirology 3 (1), 1017, 2016
2016
Recent Trends in Immunology
J Villena, H Zelaya, S Rojas-Caro, S Alvarez, A Garcia, H Kitazawa, ...
SM Online Publishers LLC, 2015
2015
14. Autoimmunity and Risk Factors in Atherosclerosis
NK Ganguly, K Kaur, D Kumar, H Lou, PK Singal
Adaptation Biology and Medicine: Volume 4, 185, 2005
2005
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20